Rapamycin

Synonyms: (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methyle thyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-2

  • Product code:LS-1056
  • CAS No.:53123-88-9
  • Formula:C51H79NO13
  • Molecular weight:914.2 g/mol

Starting at $455.00

Grouped product items
Qty Packing unit Price SKU
250 mg
$455.00
LS-1056.0250
500 mg
$585.00
LS-1056.0500
1 g
$1,007.50
LS-1056.1000
5 g
$2,145.00
LS-1056.5000
Safety Data Sheets
description

Rapamycin inhibits angiogenesis - a new candidate for combination therapy!

Rapamycin, approved by the FDA for immunosuppression in transplant patients, is currently under investigation for cancer treatment. It inhibits endothelial Akt signaling, vascular changes from myrAkt1, tumor growth, and tumor vascular permeability. In mouse models a reduced tumor growth and vascular leak has been observed. These findings make rapamycin very interesting in regimens where anti-angiogenic therapy in cancer patients is desired.

references

Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin.

Phung TL, Ziv K, Dabydeen D, Eyiah-Mensah G, Riveros M, Perruzzi C, Sun J, Monahan-Earley RA, Shiojima I, Nagy JA, Lin MI, Walsh K, Dvorak AM, Briscoe DM, Neeman M, Sessa WC,

Dvorak HF, Benjamin LE; Cancer Cell. 2006; 10(2): 159-70.

Bulk or large quantity order?

Do you need larger quantities for your development or production?

Do you need further information about this product?

get in contact

Quick contact

Please send me more information about

We found other products you might like!